Skip to main content
SpringerLink
Log in

Synthesis of reconstituted high density lipoprotein (rHDL) containing apoA-I and apoC-III: the functional role of apoC-III in rHDL

  • Published:
Molecules and Cells

Abstract

Apolipoprotein (apo) C-III is a marker protein of triacylglycerol (TG)-rich lipoproteins and high-density lipoproteins (HDL), and has been proposed as a risk factor of coronary heart disease. To compare the physiologic role of reconstituted HDL (rHDL) with or without apoC-III, we synthesized rHDL with molar ratios of apoA-I:apoC-III of 1:0, 1:0.5, 1:1, and 1:2. Increasing the apoC-III content in rHDL produced smaller rHDL particles with a lower number of apoA-I molecules. Furthermore, increasing the molar ratio of apoC-III in rHDL enhanced the surfactant-like properties and the ability to lyse dimyristoyl phosphatidylcholine. Furthermore, rHDL containing apoC-III was found to be more resistant to particle rearrangement in the presence of low-density lipoprotein (LDL) than rHDL that contained apoA-I alone. In addition, the lecithin:cholesterol acyltransferase (LCAT) activation ability was reduced as the apoC-III content of the rHDL increased; however, the CE transfer ability was not decreased by the increase of apoC-III. Finally, rHDL containing apoC-III aggravated the production of MDA in cell culture media, which led to increased cellular uptake of LDL.

Thus, the addition of apoC-III to rHDL induced changes in the structural and functional properties of the rHDL, especially in particle size and rearrangement and LCAT activation. These alterations may lead to beneficial functions of HDL, which is involved in anti-atherogenic properties in the circulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Barter, P.J., Nicholls, S., Rye, K.A., Anantharamaiah, G.M., Naval, M., and Fogelman, A.M. (2004). Antiinflammatory properties of HDL. Circ. Res. 9, 764–772.

    Article  Google Scholar 

  • Breyer, E.D., Le, N.A., Li, X., Martinson, D., and Brown, W.V. (1999). Apolipoprotein C-III displacement of apolipoprotein E from VLDL:effect of particle size. J. Lipid Res. 40, 1875–1882.

    PubMed  CAS  Google Scholar 

  • Brousseau, M.E. (2005). Emerging role of high-density lipoprotein in the prevention of cardiovascular disease. Drug Discov. Today 10, 1095–1101.

    Article  PubMed  CAS  Google Scholar 

  • Brown, M.L., Inazu, A., Hesler, C.B., Agellon, L.B., Mann, C., Whitlock, M.E., Marcel, Y.L., Milne, R.W., Koizumi, J., Mabuchi, H., et al. (1989). Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 342, 448–451.

    Article  PubMed  CAS  Google Scholar 

  • Bruns, G.A., Karathanasis, S.K., and Breslow, J.L. (1984). Human apolipoprotein A-I—C-III gene complex is located on chromosome 11. Arteriosclerosis 4, 97–102.

    PubMed  CAS  Google Scholar 

  • Cho, K.H., and Jonas, A. (2000). A key point mutation (V156E) affects the structure and functions of human apolipoprotein A-I. J. Biol. Chem 275, 26821–26827.

    PubMed  CAS  Google Scholar 

  • Cho, K.H., Lee, J.Y., Choi, M.S., Cho, J.M., Lim, J.S., and Park, Y.B. (1998). A peptide from hog plasma that inhibits human cholesteryl ester transfer protein. Biochim. Biophys. Acta 30, 133–144.

    Google Scholar 

  • Cho, K.H., Shin, D.G., Baek, S.H., and Kim, J.R. (2009). Myocardial infarction patients showed altered lipoprotein properties and functions when compared with stable angina pectoris patients. Exp. Mol. Med. 41, 67–76.

    Article  PubMed  CAS  Google Scholar 

  • Ginsberg, H.N., Le, N.A., Goldberg, I.J., Gibson, J.C., Rubinstein, A., Wang-Iverson, P., Norum, R., and Brown, W.V. (1986). Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J. Clin. Invest. 78, 1287–1295.

    Article  PubMed  CAS  Google Scholar 

  • Ginsberg, H.N., Jones, J., Blaner, W.S., Thomas, A., Karmally, W., Fields, L., Blood, D., and Begg, M.D. (1995). Association of postprandial triglyceride and retinyl plalmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle- aged men and women. Arterioscler. Thromb. Vasc. Biol. 15, 1829–1838.

    PubMed  CAS  Google Scholar 

  • Han, J.M., Jeong, T.S., Lee, W.S., Choi, I., and Cho, K.H. (2005). Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states. J. Lipid. Res. 46, 589–596.

    Article  PubMed  CAS  Google Scholar 

  • Hodis, H.N. (1999). Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation 99, 2852–2854.

    PubMed  CAS  Google Scholar 

  • Jonas, A. (1991). Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. Biochim. Biophys. Acta 1084, 205–220.

    PubMed  CAS  Google Scholar 

  • Jonas, A., Sweeny, S.A., and Herber, P.N. (1984). Discoidal complexes of A and C apolipoproteins with lipids and their reactions with lecithin:cholesterol acyltransferase. J. Biol. Chem. 259, 6369–6375.

    PubMed  CAS  Google Scholar 

  • Jonas, A., Kézdy, K.E., and Wald, J.H. (1989). Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J. Biol. Chem. 264, 4818–4824.

    PubMed  CAS  Google Scholar 

  • Jonas, A., Wald, J.H., Toohill, K.L., Krul, E.S., and Kézdy, K.E. (1990). Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. J. Biol. Chem. 265, 22123–22129.

    PubMed  CAS  Google Scholar 

  • Lee, S., Campos, H., Moye, L.A., and Sacks, F.M. (2003). LDL containing apolipoprotein C-III is an independent risk factor for coronary events in diabetic patients. Arterioscler. Thromb. Vasc. Biol. 23, 853–858

    Article  PubMed  CAS  Google Scholar 

  • Lewis, G.F., and Rader, D.J. (2005). New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96, 1221–1232.

    Article  PubMed  CAS  Google Scholar 

  • Markwell, M.A., Haas, S.M., Bieber, L.L., and Tolbert, N.E. (1978). A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87, 206–210.

    Article  PubMed  CAS  Google Scholar 

  • Matz, C.E., and Jonas, A. (1982). Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257, 4535–4540.

    PubMed  CAS  Google Scholar 

  • Nishida, H.I., Nakanishi, T., Yen, E.A., Arai, H., Yen, F.T., and Nishida, T. (1986). Nature of the enhancement of lecithincholesterol acyltransferase reaction by various apolipoproteins. J. Biol. Chem. 261, 12028–12035.

    PubMed  CAS  Google Scholar 

  • Onat, A., Hergenc, G., Sansoy, V., Fobker, M., Ceyhan, K., Toprak, S., and Assmann, G. (2003). Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. Atherosclerosis 168, 81–89.

    Article  PubMed  CAS  Google Scholar 

  • Ooi, E.M.M., Barrett, P.H.R., Chan, D.C., and Watts, G.F. (2008). Apolipoprotein C-III:understanding an emerging cardiovascular risk factor. Clin. Sci. 114, 611–624.

    Article  PubMed  CAS  Google Scholar 

  • Park, S.H., Park, J.E., Kim, Y.O., Song, K.J., Kim, S.S., Kim, J.R., Choi, I., Kim, J.J., and Cho, K.H. (2008). Function and composition of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients. Clin. Biochem. 41, 56–64.

    Article  PubMed  Google Scholar 

  • Pownall, H.J., Massey, J.B., Kusserow, S.K., and Gotto, A.M., Jr. (1978). Kinetics of lipid-protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. Biochemistry 17, 1183–1188.

    Article  PubMed  CAS  Google Scholar 

  • Sacks, F.M., Alaupovic, P., Moye, L.A., Cole, T.G., Sussex, B., Stampfer, M.J., Pfeffer, M.A., and Braunwald, E. (2000). VLDL, Apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE). Trial. Circulation 102, 1886–1892.

    CAS  Google Scholar 

  • Shachter, N.S. (2001). Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr. Opin. Lipidol. 12, 297–304.

    Article  PubMed  CAS  Google Scholar 

  • Sparks, D.L., and Pritchard, P.H. (1989). Transfer of cholesteryl ester into high density lipoprotein by cholesteryl ester transfer protein: effect of HDL lipid and apoprotein content. J. Lipid. Res. 30, 1491–1498.

    PubMed  CAS  Google Scholar 

  • Staros, J.V. (1982). N-hydroxysulfosuccinimide active esters: bis(Nhydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. Biochemistry 21, 3950–3955.

    Article  PubMed  CAS  Google Scholar 

  • Ting, H.J., Stice, J.P., Schaff, U.Y., Hui, D.Y., Rutledge, J.C., Knowlton, A.A., Passerini, A.G., and Simon, S.I. (2007). Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ. Res. 100, 381–390.

    Article  PubMed  CAS  Google Scholar 

  • Wang, C.S., McConathy, W.J., Kloer, H.U., and Alaupovic, P. (1985). Modulation of lipoprotein lipase activity by apolipoproteins. J. Clin. Invest. 75, 384–390.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Biotechnology, Aging-associated Vascular Disease Research Center, Yeungnam University, Gyeongsan, 712-749, Korea

    Kyung-Hyun Cho

Authors
  1. Kyung-Hyun Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kyung-Hyun Cho.

About this article

Cite this article

Cho, KH. Synthesis of reconstituted high density lipoprotein (rHDL) containing apoA-I and apoC-III: the functional role of apoC-III in rHDL. Mol Cells 27, 291–297 (2009). https://doi.org/10.1007/s10059-009-0037-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10059-009-0037-8

Keywords

Search

Navigation